Literature DB >> 23596002

Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.

Marion I Menzel1, Eliane V Farrell, Martin A Janich, Oleksandr Khegai, Florian Wiesinger, Stephan Nekolla, Angela M Otto, Axel Haase, Rolf F Schulte, Markus Schwaiger.   

Abstract

UNLABELLED: Abnormalities of tumor metabolism can be exploited for molecular imaging. PET imaging of (18)F-FDG is a well-established method using the avid glucose uptake of tumor cells. (13)C MR spectroscopic imaging (MRSI) of hyperpolarized [1-(13)C]pyruvate and its metabolites, meanwhile, represents a new method to study energy metabolism by visualizing, for example, the augmented lactate dehydrogenase activity in tumor cells. Because of rapid signal loss, this method underlies strict temporal limitations, and the acquisition of data-encoding spatial, temporal, and spectral information within this time frame-is challenging. The object of our study was to compare spectroscopic images with (18)F-FDG PET images for visualizing tumor metabolism in a rat model.
METHODS: (13)C MRSI with IDEAL (Iterative Decomposition of water and fat with Echo Asymmetry and Least-squares estimation) chemical shift imaging in combination with single-shot spiral acquisition was used to obtain dynamic data from 23 rats bearing a subcutaneous hepatocellular carcinoma and from reference regions of the same animals. Static and dynamic analysis of (18)F-FDG PET images of the same animals was performed. The data were analyzed qualitatively (visual assessment) and quantitatively (magnitude and dynamics of (18)F-FDG uptake, (13)C MRSI dynamics, and physiologic parameters).
RESULTS: In most animals increased [1-(13)C]lactate signals in the tumor could be detected by simple display of integrated [1-(13)C]lactate images with corresponding enhanced (18)F-FDG uptake. Low [1-(13)C]pyruvate or [1-(13)C]lactate signals did not correlate with histologic or physiologic parameters. Significantly less pyruvate reached the tumors than the gastrointestinal tract, but in tumors a significantly higher amount of pyruvate was converted to lactate and alanine within seconds after intravenous administration.
CONCLUSION: This study reveals that PET and (13)C MRSI can be used to visualize increased glycolytic flux in malignant tissue. The combination of signals will allow the quantitative dissection of substrate metabolism, with respect to uptake and downstream metabolic pathways. Although hyperpolarized [1-(13)C]pyruvate increases the sensitivity of MR imaging, signal-to-noise ratio constraints still apply for spatially and temporally resolved (13)C MRSI, emphasizing the need for further MR methodologic development. These first imaging data suggest the feasibility of (13)C MRSI for future clinical use.

Entities:  

Keywords:  13C; MR imaging; PET; animal imaging; molecular imaging

Mesh:

Substances:

Year:  2013        PMID: 23596002     DOI: 10.2967/jnumed.112.110825

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

1.  Assessing inflammatory liver injury in an acute CCl4 model using dynamic 3D metabolic imaging of hyperpolarized [1-(13)C]pyruvate.

Authors:  Sonal Josan; Kelvin Billingsley; Juan Orduna; Jae Mo Park; Richard Luong; Liqing Yu; Ralph Hurd; Adolf Pfefferbaum; Daniel Spielman; Dirk Mayer
Journal:  NMR Biomed       Date:  2015-10-16       Impact factor: 4.044

2.  Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging.

Authors:  Eugen Kubala; Kim A Muñoz-Álvarez; Geoffrey Topping; Christian Hundshammer; Benedikt Feuerecker; Pedro A Gómez; Giorgio Pariani; Franz Schilling; Steffen J Glaser; Rolf F Schulte; Marion I Menzel; Markus Schwaiger
Journal:  J Vis Exp       Date:  2016-12-30       Impact factor: 1.355

3.  Simultaneous hyperpolarized (13)C-pyruvate MRI and (18)F-FDG-PET in cancer (hyperPET): feasibility of a new imaging concept using a clinical PET/MRI scanner.

Authors:  Henrik Gutte; Adam E Hansen; Sarah T Henriksen; Helle H Johannesen; Jan Ardenkjaer-Larsen; Alexandre Vignaud; Anders E Hansen; Betina Børresen; Thomas L Klausen; Anne-Mette N Wittekind; Nic Gillings; Annemarie T Kristensen; Andreas Clemmensen; Liselotte Højgaard; Andreas Kjær
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-12-15

4.  A Landscape of Metabolic Variation across Tumor Types.

Authors:  Ed Reznik; Augustin Luna; Bülent Arman Aksoy; Eric Minwei Liu; Konnor La; Irina Ostrovnaya; Chad J Creighton; A Ari Hakimi; Chris Sander
Journal:  Cell Syst       Date:  2018-01-27       Impact factor: 10.304

5.  Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenocarcinoma.

Authors:  Kazutoshi Yamamoto; Jeffrey R Brender; Tomohiro Seki; Shun Kishimoto; Nobu Oshima; Rajani Choudhuri; Stephen S Adler; Elaine M Jagoda; Keita Saito; Nallathamby Devasahayam; Peter L Choyke; James B Mitchell; Murali C Krishna
Journal:  Cancer Res       Date:  2020-04-03       Impact factor: 12.701

Review 6.  The use of dynamic nuclear polarization (13)C-pyruvate MRS in cancer.

Authors:  Henrik Gutte; Adam Espe Hansen; Helle Hjorth Johannesen; Andreas Ettrup Clemmensen; Jan Henrik Ardenkjær-Larsen; Carsten Haagen Nielsen; Andreas Kjær
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

Review 7.  Hyperpolarized MRI, functional MRI, MR spectroscopy and CEST to provide metabolic information in vivo.

Authors:  Peter C M van Zijl; Kevin Brindle; Hanzhang Lu; Peter B Barker; Richard Edden; Nirbhay Yadav; Linda Knutsson
Journal:  Curr Opin Chem Biol       Date:  2021-07-20       Impact factor: 8.972

8.  Simultaneous PET/MRI with (13)C magnetic resonance spectroscopic imaging (hyperPET): phantom-based evaluation of PET quantification.

Authors:  Adam E Hansen; Flemming L Andersen; Sarah T Henriksen; Alexandre Vignaud; Jan H Ardenkjaer-Larsen; Liselotte Højgaard; Andreas Kjaer; Thomas L Klausen
Journal:  EJNMMI Phys       Date:  2016-04-22

Review 9.  Potential Clinical Roles for Metabolic Imaging with Hyperpolarized [1-(13)C]Pyruvate.

Authors:  Eva M Serrao; Kevin M Brindle
Journal:  Front Oncol       Date:  2016-03-11       Impact factor: 6.244

Review 10.  Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.

Authors:  Gigin Lin; Yuen-Li Chung
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.